设为首页收藏本站

中国病毒学论坛|我们一直在坚持!

 找回密码
 立即注册

QQ登录

只需一步,快速开始

搜索
热搜: 活动 交友 discuz
查看: 1296|回复: 0
打印 上一主题 下一主题

Epitranscriptomic Addition of m5C to HIV-1 Transcripts Regulates Viral Gene E...

[复制链接]

2204

帖子

2852

学分

3万

金币

管理员

Rank: 9Rank: 9Rank: 9Rank: 9

积分
2852
跳转到指定楼层
楼主
发表于 2019-8-21 13:27:51 | 只看该作者 回帖奖励 |倒序浏览 |阅读模式
Epitranscriptomic Addition of m5C to HIV-1 Transcripts Regulates Viral Gene Expression
Highlights
  • •HIV-1 mRNA in infected cells are highly modified by addition of m 5C
  • •These m 5C residues are added in the nucleus by the host NSUN2 methyltransferase
  • •Loss of NSUN2, and hence loss of m 5C addition, inhibits HIV-1 mRNA translation
  • •NSUN2 deficiency perturbs ribosomal recruitment and HIV-1 RNA alternative splicing

SummaryHow the covalent modification of mRNA ribonucleotides, termed epitranscriptomic modifications, alters mRNA function remains unclear. One issue has been the difficulty of quantifying these modifications. Using purified HIV-1 genomic RNA, we show that this RNA bears more epitranscriptomic modifications than the average cellular mRNA, with 5-methylcytosine (m 5C) and 2′O-methyl modifications being particularly prevalent. The methyltransferase NSUN2 serves as the primary writer for m 5C on HIV-1 RNAs. NSUN2 inactivation inhibits not only m 5C addition to HIV-1 transcripts but also viral replication. This inhibition results from reduced HIV-1 protein, but not mRNA, expression, which in turn correlates with reduced ribosome binding to viral mRNAs. In addition, loss of m 5C dysregulates the alternative splicing of viral RNAs. These data identify m 5C as a post-transcriptional regulator of both splicing and function of HIV-1 mRNA, thereby affecting directly viral gene expression.
DOI:https://doi.org/10.1016/j.chom.2019.07.005


分享到:  QQ好友和群QQ好友和群 QQ空间QQ空间 腾讯微博腾讯微博 腾讯朋友腾讯朋友
收藏收藏 分享分享 支持支持 反对反对
您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

QQ|论坛App下载|Archiver|小黑屋|中国病毒学论坛    

GMT+8, 2024-4-27 06:27 , Processed in 0.076708 second(s), 28 queries .

Powered by Discuz! X3.2

© 2001-2013 Comsenz Inc.

快速回复 返回顶部 返回列表